{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:14:48Z","timestamp":1772165688291,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-025-01868-x","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T08:20:58Z","timestamp":1754986858000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Predicting preoperative lymph node metastasis in patients with high-grade serous ovarian cancer by using intratumoral and peritumoral radiomics: a retrospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Silin","family":"Nie","sequence":"first","affiliation":[]},{"given":"Yumin","family":"Jiang","sequence":"additional","affiliation":[]},{"given":"Huixiang","family":"Ji","sequence":"additional","affiliation":[]},{"given":"Xiaohui","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Lanxing","family":"Lyu","sequence":"additional","affiliation":[]},{"given":"Chun","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Yuping","family":"Shan","sequence":"additional","affiliation":[]},{"given":"Aiping","family":"Chen","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"issue":"2","key":"1868_CR1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.6004\/jnccn.2021.0007","volume":"19","author":"DK Armstrong","year":"2021","unstructured":"Armstrong DK, et al. Ovarian cancer, version 2.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(2):191\u2013226.","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"1868_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5528\/wjtm.v3.i1.1","volume":"3","author":"A Desai","year":"2014","unstructured":"Desai A, et al. Epithelial ovarian cancer: an overview. World J Translational Med. 2014;3(1):1.","journal-title":"World J Translational Med"},{"issue":"4","key":"1868_CR3","doi-asserted-by":"publisher","first-page":"952","DOI":"10.3390\/ijms20040952","volume":"20","author":"M-A Lisio","year":"2019","unstructured":"Lisio M-A, Fu L, Goyeneche A, Gao Z-h, Telleria C. High-grade serous ovarian cancer: basic sciences, clinical and therapeutic standpoints. Int J Mol Sci. 2019;20(4):952.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"1868_CR4","doi-asserted-by":"publisher","first-page":"972","DOI":"10.6004\/jnccn.2022.0047","volume":"20","author":"DK Armstrong","year":"2022","unstructured":"Armstrong DK, et al. NCCN guidelines\u00ae insights: ovarian cancer, version 3.2022: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2022;20(9):972\u201380.","journal-title":"J Natl Compr Canc Netw"},{"key":"1868_CR5","doi-asserted-by":"crossref","unstructured":"Stewart C, Ralyea C, Lockwood S. Ovarian cancer: an integrated review. Seminars in oncology nursing. Elsevier. 2019;35(2):151\u20136.","DOI":"10.1016\/j.soncn.2019.02.001"},{"key":"1868_CR6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.9495","author":"G Caruso","year":"2025","unstructured":"Caruso G, Weroha SJ, Cliby W. Ovarian Cancer: Rev JAMA. 2025. https:\/\/doi.org\/10.1001\/jama.2025.9495.","journal-title":"Ovarian Cancer: Rev JAMA"},{"issue":"3","key":"1868_CR7","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.3802\/jgo.2021.32.e40","volume":"32","author":"T Deng","year":"2021","unstructured":"Deng T, et al. The impact of lymph node dissection on survival in patients with clinical early-stage ovarian cancer. J Gynecologic Oncol. 2021;32(3):e40.","journal-title":"J Gynecologic Oncol"},{"issue":"1","key":"1868_CR8","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s12957-024-03571-7","volume":"22","author":"H Wang","year":"2024","unstructured":"Wang H, Wang S, Wang P, Han Y. Survival outcomes of lymph node dissection in early-stage epithelial ovarian cancer: identifying suitable candidates. World J Surg Oncol. 2024;22(1):294.","journal-title":"World J Surg Oncol"},{"key":"1868_CR9","doi-asserted-by":"crossref","unstructured":"Harter P et al. How to manage lymph nodes in ovarian cancer. Cancer. 2019;125:4573\u20134577.","DOI":"10.1002\/cncr.32514"},{"issue":"9","key":"1868_CR10","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1056\/NEJMoa1808424","volume":"380","author":"P Harter","year":"2019","unstructured":"Harter P, et al. A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms. N Engl J Med. 2019;380(9):822\u201332.","journal-title":"N Engl J Med"},{"key":"1868_CR11","doi-asserted-by":"crossref","unstructured":"Classe J-M, et al. Omission of lymphadenectomy in patients with advanced epithelial ovarian cancer treated with primary or interval cytoreductive surgery after neoadjuvant chemotherapy: the CARACO phase III randomized trial. J Clin Oncol. 2024.","DOI":"10.1200\/JCO.2024.42.17_suppl.LBA5505"},{"key":"1868_CR12","doi-asserted-by":"publisher","unstructured":"Iida Y, Kobayashi-Kato M, Komatsu H, Ishikawa M, Satoh T. and G. Gynecologic cancer study group of the Japan clinical oncology, questionnaire-based survey on the extent of lymph node dissection during interval debulking surgery after neoadjuvant chemotherapy for patients with advanced ovarian cancer in the gynecologic cancer study group of JCOG. Int J Clin Oncol. 2025\/05\/01 2025;30(5):1040\u20137. https:\/\/doi.org\/10.1007\/s10147-025-02734-0","DOI":"10.1007\/s10147-025-02734-0"},{"issue":"2","key":"1868_CR13","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00404-022-06595-0","volume":"307","author":"K Matsuo","year":"2023","unstructured":"Matsuo K, et al. Utilization of Sentinel lymph node biopsy in the early ovarian cancer surgery. Arch Gynecol Obstet. 2023;307(2):525\u201332.","journal-title":"Arch Gynecol Obstet"},{"key":"1868_CR14","doi-asserted-by":"crossref","unstructured":"Skanjeti A, Dhomps A, Paschetta C, Tordo J, Giammarile F. Sentinel node mapping in gynecologic cancers: a comprehensive review. Semin Nucl Med. Elsevier. 2019;49(6)521\u201333.","DOI":"10.1053\/j.semnuclmed.2019.06.012"},{"issue":"4","key":"1868_CR15","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ajog.2019.05.005","volume":"221","author":"S Uccella","year":"2019","unstructured":"Uccella S, et al. Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY). Am J Obstet Gynecol. 2019;221(4):324. e1-324. e10.","journal-title":"Am J Obstet Gynecol"},{"key":"1868_CR16","doi-asserted-by":"publisher","first-page":"999749","DOI":"10.3389\/fonc.2022.999749","volume":"12","author":"NC Kampan","year":"2022","unstructured":"Kampan NC, Teik CK, Shafiee MN. Where are we going with Sentinel nodes mapping in ovarian cancer? Front Oncol. 2022;12:999749.","journal-title":"Front Oncol"},{"key":"1868_CR17","doi-asserted-by":"crossref","unstructured":"Euscher ED, Malpica A. Gynaecological malignancies and sentinel lymph node mapping: an update, Histopathology. 2020;76(1):139\u2013150.","DOI":"10.1111\/his.14017"},{"key":"1868_CR18","doi-asserted-by":"crossref","unstructured":"Sohn JH, Fields BK. Radiomics and deep learning to predict pulmonary nodule metastasis at CT. ed: Radiological Society of North America. 2024;311:e233356.","DOI":"10.1148\/radiol.233356"},{"issue":"2","key":"1868_CR19","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1007\/s00330-023-10108-1","volume":"34","author":"P-c Zhan","year":"2024","unstructured":"Zhan P-c, et al. Radiomics using CT images for preoperative prediction of lymph node metastasis in Perihilar cholangiocarcinoma: a multi-centric study. Eur Radiol. 2024;34(2):1280\u201391.","journal-title":"Eur Radiol"},{"key":"1868_CR20","doi-asserted-by":"crossref","unstructured":"Castellana R, Fanni SC, Roncella C, Romei C, Natrella M, Neri E. Radiomics and deep learning models for CT pre-operative lymph node staging in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis. Eur J Radiol. 2024;111510.","DOI":"10.1016\/j.ejrad.2024.111510"},{"key":"1868_CR21","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1007\/s00330-010-1886-4","volume":"20","author":"R Forstner","year":"2010","unstructured":"Forstner R, Sala E, Kinkel K, Spencer JA. ESUR guidelines: ovarian cancer staging and follow-up. Eur Radiol. 2010;20:2773\u201380.","journal-title":"Eur Radiol"},{"issue":"5","key":"1868_CR22","first-page":"3451","volume":"19","author":"S-S Miao","year":"2020","unstructured":"Miao S-S, et al. Contrast-enhanced CT imaging for the assessment of lymph node status in patients with colorectal cancer. Oncol Lett. 2020;19(5):3451\u20138.","journal-title":"Oncol Lett"},{"key":"1868_CR23","doi-asserted-by":"crossref","unstructured":"Tomita H et al. Nodal-based radiomics analysis for identifying cervical lymph node metastasis at levels I and II in patients with oral squamous cell carcinoma using contrast-enhanced computed tomography. Eur Radiol. 2021;1\u201310.","DOI":"10.1007\/s00330-021-07758-4"},{"issue":"1","key":"1868_CR24","doi-asserted-by":"publisher","first-page":"10829","DOI":"10.1038\/s41598-021-90367-4","volume":"11","author":"SK Das","year":"2021","unstructured":"Das SK, Fang K-W, Xu L, Li B, Zhang X, Yang H-F. Integrative nomogram of intratumoral, peritumoral, and lymph node radiomic features for prediction of lymph node metastasis in cT1N0M0 lung adenocarcinomas. Sci Rep. 2021;11(1):10829.","journal-title":"Sci Rep"},{"key":"1868_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fonc.2020.00053","volume":"10","author":"Q Sun","year":"2020","unstructured":"Sun Q, et al. Deep learning vs. radiomics for predicting axillary lymph node metastasis of breast cancer using ultrasound images: don\u2019t forget the peritumoral region. Front Oncol. 2020;10:53.","journal-title":"Front Oncol"},{"issue":"5","key":"1868_CR26","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.3802\/jgo.2022.33.e69","volume":"33","author":"G Caruso","year":"2022","unstructured":"Caruso G, et al. Systematic lymph node dissection during interval debulking surgery for advanced epithelial ovarian cancer: a systematic review and meta-analysis. J Gynecologic Oncol. 2022;33(5):e69.","journal-title":"J Gynecologic Oncol"},{"key":"1868_CR27","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Ovarian Cancer, Version 1.2025, 2025. [Online]. Available: https:\/\/www.nccn.org\/"},{"key":"1868_CR28","doi-asserted-by":"crossref","unstructured":"Rizzo S et al. Ovarian cancer staging and follow-up: updated guidelines from the European society of urogenital radiology female pelvic imaging working group. Eur Radiol. 2025;1\u201311.","DOI":"10.1007\/s00330-024-11300-7"},{"issue":"1","key":"1868_CR29","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1186\/s12885-025-14237-2","volume":"25","author":"W Guo","year":"2025","unstructured":"Guo W, et al. Patients with macroscopic lymph node metastasis expect poor prognosis after neoadjuvant chemotherapy in advanced ovarian cancer: a retrospective cohort study based on a single gynecological team. BMC Cancer. 2025;25(1):832.","journal-title":"BMC Cancer"},{"issue":"19","key":"1868_CR30","doi-asserted-by":"publisher","first-page":"4689","DOI":"10.7150\/jca.29896","volume":"10","author":"D Nie","year":"2019","unstructured":"Nie D, Mao X, Li Z. Prognostic value of lymph nodes ratio in patients with stage III ovarian clear cell carcinoma: A retrospective study of patients in Southwest China. J Cancer. 2019;10(19):4689.","journal-title":"J Cancer"},{"key":"1868_CR31","doi-asserted-by":"publisher","first-page":"711648","DOI":"10.3389\/fonc.2021.711648","volume":"11","author":"H-z Chen","year":"2021","unstructured":"Chen H-z, et al. The development and validation of a CT-based radiomics nomogram to preoperatively predict lymph node metastasis in high-grade serous ovarian cancer. Front Oncol. 2021;11:711648.","journal-title":"Front Oncol"},{"issue":"1","key":"1868_CR32","doi-asserted-by":"publisher","first-page":"12456","DOI":"10.1038\/s41598-024-63369-1","volume":"14","author":"Y Leng","year":"2024","unstructured":"Leng Y, et al. Development and validation of radiomics nomogram for metastatic status of epithelial ovarian cancer. Sci Rep. 2024;14(1):12456.","journal-title":"Sci Rep"},{"key":"1868_CR33","doi-asserted-by":"publisher","unstructured":"Caruso G, et al. Systematic lymph node dissection during interval debulking surgery for advanced epithelial ovarian cancer: a systematic review and meta-analysis, (in eng). J Gynecol Oncol. Sep 2022;33(5):e69. https:\/\/doi.org\/10.3802\/jgo.2022.33.e69.","DOI":"10.3802\/jgo.2022.33.e69"},{"issue":"3","key":"1868_CR34","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.ygyno.2021.06.025","volume":"162","author":"L Benoit","year":"2021","unstructured":"Benoit L, et al. What can we learn from the 10\u00a0mm lymph node size cut-off on the CT in advanced ovarian cancer at the time of interval debulking surgery? Gynecol Oncol. 2021;162(3):667\u201373. https:\/\/doi.org\/10.1016\/j.ygyno.2021.06.025. 2021\/09\/01\/.","journal-title":"Gynecol Oncol"},{"key":"1868_CR35","doi-asserted-by":"publisher","unstructured":"Pinelli C et al. The feasibility of cardiophrenic lymphnode assessment and removal in patients requiring diaphragmatic resection during interval debulking surgery for ovarian cancer. J Invest Surg. 2021\/08\/09 2021;34(7):756\u201362. https:\/\/doi.org\/10.1080\/08941939.2019.1690077","DOI":"10.1080\/08941939.2019.1690077"},{"issue":"6","key":"1868_CR36","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.1007\/s00330-023-10455-z","volume":"34","author":"L Russo","year":"2024","unstructured":"Russo L, Bottazzi S, Sala E. Artificial intelligence in female pelvic oncology: tailoring applications to clinical needs. Eur Radiol. 2024;34(6):4038\u201340.","journal-title":"Eur Radiol"},{"key":"1868_CR37","doi-asserted-by":"publisher","first-page":"1185663","DOI":"10.3389\/fonc.2023.1185663","volume":"13","author":"Z HajiEsmailpoor","year":"2023","unstructured":"HajiEsmailpoor Z, Tabnak P, Baradaran B, Pashazadeh F, Aghebati-Maleki L. Diagnostic performance of CT scan\u2013based radiomics for prediction of lymph node metastasis in gastric cancer: a systematic review and meta-analysis. Front Oncol. 2023;13:1185663.","journal-title":"Front Oncol"},{"issue":"1","key":"1868_CR38","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41392-023-01576-4","volume":"8","author":"H Ji","year":"2023","unstructured":"Ji H, et al. Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic interventions. Signal Transduct Target Therapy. 2023;8(1):367.","journal-title":"Signal Transduct Target Therapy"},{"issue":"3","key":"1868_CR39","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE De Visser","year":"2023","unstructured":"De Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41(3):374\u2013403.","journal-title":"Cancer Cell"},{"key":"1868_CR40","unstructured":"Fang Y, Yan Y. Tumor microenvironment-the critical element of tumor metastasis. Zhongguo Fei Ai Za Zhi. 2015;18(1)."},{"key":"1868_CR41","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fonc.2013.00097","volume":"3","author":"MP Steinkamp","year":"2013","unstructured":"Steinkamp MP, et al. Ovarian tumor attachment, invasion, and vascularization reflect unique microenvironments in the peritoneum: insights from xenograft and mathematical models. Front Oncol. 2013;3:97.","journal-title":"Front Oncol"},{"key":"1868_CR42","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fonc.2017.00024","volume":"7","author":"T Worzfeld","year":"2017","unstructured":"Worzfeld T, et al. The unique molecular and cellular microenvironment of ovarian cancer. Front Oncol. 2017;7:24.","journal-title":"Front Oncol"},{"issue":"2","key":"1868_CR43","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00261-022-03717-9","volume":"48","author":"Y Wu","year":"2023","unstructured":"Wu Y, Jiang W, Fu L, Ren M, Ai H, Wang X. Intra-and peritumoral radiomics for predicting early recurrence in patients with high-grade serous ovarian cancer. Abdom Radiol. 2023;48(2):733\u201343.","journal-title":"Abdom Radiol"},{"issue":"2","key":"1868_CR44","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.acra.2024.09.001","volume":"32","author":"X Huang","year":"2025","unstructured":"Huang X, et al. Intratumoral and peritumoral radiomics for predicting the prognosis of high-grade serous ovarian cancer patients receiving platinum-based chemotherapy. Acad Radiol. 2025;32(2):877\u201387.","journal-title":"Acad Radiol"},{"issue":"1","key":"1868_CR45","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s13244-024-01855-w","volume":"15","author":"X Wang","year":"2024","unstructured":"Wang X, et al. Intratumoral and peritumoral MRI-based radiomics for predicting extrapelvic peritoneal metastasis in epithelial ovarian cancer. Insights into Imaging. 2024;15(1):281.","journal-title":"Insights into Imaging"},{"key":"1868_CR46","doi-asserted-by":"publisher","first-page":"1381268","DOI":"10.3389\/fonc.2024.1381268","volume":"14","author":"L Song","year":"2024","unstructured":"Song L, Wu Q, Bai S, Zhao J, Qi J, Zhang J. Comparison of the diagnostic efficacy of systemic inflammatory indicators in the early diagnosis of ovarian cancer. Front Oncol. 2024;14:1381268.","journal-title":"Front Oncol"},{"issue":"3","key":"1868_CR47","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.ygyno.2011.09.013","volume":"123","author":"M Kleppe","year":"2011","unstructured":"Kleppe M, Wang T, Van Gorp T, Slangen B, Kruse AJ, Kruitwagen R. Lymph node metastasis in stages I and II ovarian cancer: a review. Gynecol Oncol. 2011;123(3):610\u20134.","journal-title":"Gynecol Oncol"},{"issue":"36","key":"1868_CR48","doi-asserted-by":"publisher","first-page":"5093","DOI":"10.2217\/fon-2021-0419","volume":"17","author":"D Atallah","year":"2021","unstructured":"Atallah D, et al. Predictive factors of lymph node metastasis and pattern of repartition in patients with epithelial ovarian cancer. Future Oncol. 2021;17(36):5093\u2013101.","journal-title":"Future Oncol"},{"issue":"3","key":"1868_CR49","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ygyno.2011.05.001","volume":"122","author":"CA Powless","year":"2011","unstructured":"Powless CA, Aletti GD, Bakkum-Gamez JN, Cliby WA. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging. Gynecol Oncol. 2011;122(3):536\u201340.","journal-title":"Gynecol Oncol"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01868-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-01868-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01868-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T11:19:57Z","timestamp":1757416797000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-025-01868-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1868"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-01868-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6437209\/v1","asserted-by":"object"}]},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]},"assertion":[{"value":"13 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was reviewed and approved by the Ethics Committees of the Affiliated Hospital of Qingdao University and Rizhao People\u2019s Hospital. Written informed consent was waived due to the retrospective nature of the study, and patient data confidentiality was strictly ensured. All methods were carried out in accordance with relevant guidelines and regulations, including the ethical principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"323"}}